These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3300969)

  • 21. Phase II study on oral N-methylformamide in metastatic colorectal cancer.
    Planting AS; Klijn JG; Verweij J; Stoter G
    Cancer Treat Rep; 1987 Dec; 71(12):1293-4. PubMed ID: 3690540
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
    Kemeny N; Yagoda A; Burchenal JH
    Cancer Treat Rep; 1978 Mar; 62(3):463-4. PubMed ID: 77190
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Currie V
    Cancer Treat Rep; 1981; 65(1-2):127-8. PubMed ID: 7226162
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II study of Baker's antifol in advanced colorectal cancer.
    Padilla F; Correa J; Buroker T; Vaitkevicius VK
    Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
    [No Abstract]   [Full Text] [Related]  

  • 25. Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer.
    Cantrell JE; Hart RD; Taylor RF; Harvey JH
    Cancer Treat Rep; 1987 Jun; 71(6):615-8. PubMed ID: 3555789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in gastrointestinal cancer].
    Takenaka K; Tamada R; Hiramoto Y; Inokuchi K; Saku M; Oka N; Kano T; Noda S; Nagasaki S; Toda T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2155-60. PubMed ID: 4062315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.
    Posner MR; Belliveau JF; Weitberg AB; Sabbath K; Wiemann MC; Cummings FJ; Calabresi P
    Cancer Treat Rep; 1987 Oct; 71(10):975-7. PubMed ID: 3308082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.
    Carlson RW; Williams RD; Billingham ME; Kohler M; Torti FM
    Cancer Treat Rep; 1987; 71(7-8):767-8. PubMed ID: 3607787
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
    Kris MG; Gralla RJ; Burke MT; Fiore JJ; Kelsen DP; Marks LD; Heelan RT
    Cancer Treat Rep; 1987; 71(7-8):783-4. PubMed ID: 3038319
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of metronidazole therapy for advanced colorectal carcinoma.
    Frytak S; Moertel CG; Childs DS; Schutt AJ; Albers JW
    Cancer Treat Rep; 1978 Mar; 62(3):483-5. PubMed ID: 348320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
    Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
    Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trial of UFT in recurrent or advanced cancer].
    Kunitomo K; Kuwashima T; Korematsu H; Tamura T; Yoshikawa H; Toyosaki M; Komi N
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):72-8. PubMed ID: 6820878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.
    Bellet RE; Engstrom PF; Catalano RB; Creech RH; Mastrangelo MJ
    Cancer Treat Rep; 1976 Sep; 60(9):1395-7. PubMed ID: 1016973
    [No Abstract]   [Full Text] [Related]  

  • 36. High-dose intermittent iv 5-FU and melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM
    Cancer Treat Rep; 1983 Jun; 67(6):595-6. PubMed ID: 6344994
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
    Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 39. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
    Britell JC; Moertel CG; Kvols LK; O'Connell MJ; Rubin J; Schutt AJ
    Cancer Treat Rep; 1981; 65(9-10):909-10. PubMed ID: 7273027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.